CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +26,411 | 177,329 | ||
| 2025-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −7,953 | $30.52 | $243K | 169,376 |
| 2025-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −21,670 | $30.52 | $661K | 147,706 |
| 2025-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +51,768 | 182,613 | ||
| 2025-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +26,957 | 209,570 | ||
| 2025-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −8,109 | $30.52 | $247K | 201,461 |
| 2025-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −22,317 | $30.52 | $681K | 179,144 |
| 2025-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +40,965 | 160,149 | ||
| 2025-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +29,030 | 189,179 | ||
| 2025-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −9,826 | $30.52 | $300K | 179,353 |
| 2025-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −25,149 | $30.52 | $768K | 154,204 |
| 2025-02-04 | Lurker Nancy Director | Grant or award | +12,726 | 12,726 | ||
| 2025-01-10 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise 10b5-1 | +27,500 | $21.34 | $587K | 146,684 |
| 2025-01-10 | Kuhlmann Shirley R. EVP and General Counsel | Sale 10b5-1 | −21,400 | $32.87 | $703K | 125,284 |
| 2025-01-10 | Kuhlmann Shirley R. EVP and General Counsel | Sale 10b5-1 | −6,100 | $33.64 | $205K | 119,184 |
| 2025-01-10 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −27,500 | 0 | ||
| 2024-11-12 | Karnani Vikram President and CEO | Grant or award | +105,972 | 105,972 | ||
| 2024-11-12 | Karnani Vikram President and CEO | Grant or award · Stock Option (Right to Purchase) | +130,344 | 130,344 | ||
| 2024-09-13 | Smith Thomas B EVP and Chief Medical Officer | Sale | −9,593 | $36.62 | $351K | 53,816 |
| 2024-09-06 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −977 | $37.46 | $37K | 119,184 |
Page 6 of 24 · 462 trades